FGF21 and hydrops fetalis: Interestingly, improvement in progressive liver damage by this co-treatment occurred despite a decrease in hepatic fibroblast growth factor 21 (FGF21) expression and serum FGF21 levels, which suggests amelioration of hepatic ER stress and FGF21 resistance induced by HF-CDAA30.